164 related articles for article (PubMed ID: 34192561)
1. Downregulation of DNMT3a expression by RNAi and its effect on NF-κBs expression of thymic epithelial cells.
Meng FJ; Guo F; Sun ZN; Wang SJ; Yang CR; Wang CY; Zhang WC; Gao ZY; Ji LL; Feng FK; Guan ZY; Wang GS
Immunol Lett; 2021 Sep; 237():17-26. PubMed ID: 34192561
[TBL] [Abstract][Full Text] [Related]
2. Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis.
Guo F; Wang CY; Wang S; Zhang J; Yan YJ; Guan ZY; Meng FJ
Thorac Cancer; 2019 Mar; 10(3):564-570. PubMed ID: 30734484
[TBL] [Abstract][Full Text] [Related]
3. Infrequent and low AIRE expression in thymoma: difference in AIRE expression among WHO subtypes does not correlate with association of MG.
Suzuki E; Kobayashi Y; Yano M; Fujii Y
Autoimmunity; 2008 Aug; 41(5):377-82. PubMed ID: 18568643
[TBL] [Abstract][Full Text] [Related]
4. Analysis of TNF-related apoptosis-inducing ligand and receptors and implications in thymus biology and myasthenia gravis.
Kanatli I; Akkaya B; Uysal H; Kahraman S; Sanlioglu AD
Neuromuscul Disord; 2017 Feb; 27(2):128-135. PubMed ID: 28012741
[TBL] [Abstract][Full Text] [Related]
5. Muscle nicotinic acetylcholine receptor mRNA expression in hyperplastic and neoplastic myasthenia gravis thymus.
MacLennan CA; Beeson D; Willcox N; Vincent A; Newsom-Davis J
Ann N Y Acad Sci; 1998 May; 841():407-10. PubMed ID: 9668266
[No Abstract] [Full Text] [Related]
6. Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour.
Chang KC; Wu MH; Jones D; Chen FF; Tseng YL
J Pathol; 2006 Oct; 210(2):224-33. PubMed ID: 16917804
[TBL] [Abstract][Full Text] [Related]
7. LncRNA XLOC_003810 modulates thymic Th17/Treg balance in myasthenia gravis with thymoma.
Niu L; Jiang J; Yin Y; Hu B
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):989-996. PubMed ID: 32048308
[TBL] [Abstract][Full Text] [Related]
8. Gene-Specific Methylation Analysis in Thymomas of Patients with Myasthenia Gravis.
Lopomo A; Ricciardi R; Maestri M; De Rosa A; Melfi F; Lucchi M; Mussi A; Coppedè F; Migliore L
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999265
[TBL] [Abstract][Full Text] [Related]
9. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes.
Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A
Front Immunol; 2020; 11():664. PubMed ID: 32373124
[TBL] [Abstract][Full Text] [Related]
10. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes.
Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H
BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429
[TBL] [Abstract][Full Text] [Related]
11. Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients.
Marie J; Wakkach A; Coudray A; Chastre E; Berrih-Aknin S; Gespach C
J Immunol; 1999 Feb; 162(4):2103-12. PubMed ID: 9973484
[TBL] [Abstract][Full Text] [Related]
12. Different patterns of nicotinic acetylcholine receptor subunit transcription in human thymus.
Bruno R; Sabater L; Tolosa E; Sospedra M; Ferrer-Francesch X; Coll J; Foz M; Melms A; Pujol-Borrell R
J Neuroimmunol; 2004 Apr; 149(1-2):147-59. PubMed ID: 15020075
[TBL] [Abstract][Full Text] [Related]
13. Genetic characterization of thymoma.
Yu L; Ke J; Du X; Yu Z; Gao D
Sci Rep; 2019 Feb; 9(1):2369. PubMed ID: 30787364
[TBL] [Abstract][Full Text] [Related]
14. [The level of Bcl-2 and Fas expression in thymoma tissue from patients with myasthenia gravis].
Shen G; Chai Y; Yue L; Wei HQ; Lin M
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr; 29(4):240-2. PubMed ID: 16750039
[TBL] [Abstract][Full Text] [Related]
15. LncRNA and mRNA expression associated with myasthenia gravis in patients with thymoma.
Ke J; Du X; Cui J; Yu L; Li H
Thorac Cancer; 2022 Jan; 13(1):15-23. PubMed ID: 34773374
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune regulator expression in thymomas with or without autoimmune disease.
Liu Y; Zhang H; Zhang P; Meng F; Chen Y; Wang Y; Yao Y; Qi B
Immunol Lett; 2014 Sep; 161(1):50-6. PubMed ID: 24768600
[TBL] [Abstract][Full Text] [Related]
17. Different molecular expression in thymoma with ocular or generalized myasthenia gravis.
Zhang M; Li H; Guo J; Zhou Y; Gong L; Wang X; Li Z; Zhang W
J Neurol Sci; 2012 Feb; 313(1-2):27-31. PubMed ID: 22000402
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of thymoma with myasthenia gravis: Risk factors of developing myasthenia gravis in thymoma patients.
Lee MC; Hsiao TH; Chuang HN; Lee LW; Chi PL; Tsai HM; Mao CL; Hsu CP
Lung Cancer; 2020 Jan; 139():157-164. PubMed ID: 31809976
[TBL] [Abstract][Full Text] [Related]
19. Expression of receptor for advanced glycation end-products (RAGE) in thymus from myasthenia patients.
Bouchikh M; Zouaidia F; Benhaddou EHA; Mahassini N; Achir A; El Malki HO
Rev Neurol (Paris); 2017 Jun; 173(6):388-395. PubMed ID: 28461027
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centers.
Lefeuvre CM; Payet CA; Fayet OM; Maillard S; Truffault F; Bondet V; Duffy D; de Montpreville V; Ghigna MR; Fadel E; Mansuet-Lupo A; Alifano M; Validire P; Gossot D; Behin A; Eymard B; Berrih-Aknin S; Le Panse R
J Autoimmun; 2020 Jan; 106():102337. PubMed ID: 31594658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
